Jinling Pharmaceutical: Subsidiary receives notice of approval for listing application of ferrous fumarate chemical raw materials.

Jingling Pharmaceutical announced that its subsidiary, Chizhou Dongsheng Pharmaceutical Co., Ltd., has recently received a notification of approval for the application for listing of chemical raw materials from the National Medical Products Administration. It has been approved to register ferrous succinate raw materials, which are mainly used for the prevention and treatment of iron deficiency anemia. This approval will further enrich the company's raw materials product line, promote the integrated development of raw materials and preparations industry chains, and enhance the market competitiveness of its main product, ferrous succinate tablets.